ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 347

Factors Explaining The Discrepancy Between Patient and Physician Global Assessment Of Disease Activity In Psoriatic Arthritis

Lihi Eder1, Arane Thavaneswaran1, Vinod Chandran2, Richard J. Cook3 and Dafna D. Gladman2, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: outcome measures and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment: Psoriatic Arthritis: Clinical Aspects and Treatment I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients and physicians often perceive the extent of disease activity differently. We aimed to assess the factors contributing to the variability in scoring of patient global assessment (PGA), physician (assessor) global assessment (AGA) of disease activity and the discrepancy in scoring between PGA and AGA among patients with psoriatic arthritis (PsA).

Methods: A cross sectional study was conducted of patients attending a large PsA clinic from 2008 to 2013. Three different outcomes were studied: AGA, PGA and the difference between AGA and PGA. The scores of PGA and AGA ranged from 0 (no disease activity) to 10 (high disease activity). The difference between AGA and PGA reflected the discrepancy between the physician and patient global assessment of joint activity and could take values from -10 (worse estimation of disease activity by the patient) to 10 (worse estimation of disease activity by the physician). Predictors of these outcomes included demographics, skin and joint assessment by the physician, patient reported information about function, quality of life and fatigue. Multivariate linear regression identified variables that contributed significantly to each of the outcomes. The proportion of variability of each outcome explained by each predictor was expressed using a partial R2. 

Results: A total of 565 patients were included in the analysis. Their mean age was 51.7±13.2 years and 58.6% were males. The mean duration of psoriasis and PsA were 24±13.8 and 14.3±19.4 years, respectively. 81% of the variability in PGA and 68% of the variability in AGA were explainable. The main factors associated with PGA were pain (R2partial =72.9%, Figure 1), fatigue (by Fatigue Severity Scale (FSS) R2partial =5.5%) and disability scores (by Short Form (SF) -36 R2partial =2.1%). The main factors associated with AGA were tender joint count (R2partial =53.9%), swollen joint count (R2partial =4.2%) and patient perception of joint activity (by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) R2partial =7.5%). Increased fatigue by FSS accounted for 20.4% of the variation in the difference between AGA and PGA and pain (R2partial =9.2%) and disability scores by SF-36 (R2partial =1.6%) were also important; these led to worse patient assessments while increased tender joint count (R2partial =15.9%) and swollen joint counts (R2partial =1.7%) resulted in a worse physician assessment of arthritis.

Conclusion: Fatigue, pain, disability, tender and swollen joint counts were the most important factors contributing to discrepancy between patient and physician assessment of joint activity.

 


Disclosure:

L. Eder,
None;

A. Thavaneswaran,
None;

V. Chandran,
None;

R. J. Cook,
None;

D. D. Gladman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-explaining-the-discrepancy-between-patient-and-physician-global-assessment-of-disease-activity-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology